This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Dana-Farber-Cancer Institute Inc., The General Hospital Corporation. Active years: 2007-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boston, MA (US) (2007 - 2013)
- Dean Funes, AR (2015 - 2020)
Company Filing History:
7 out of 1,268 
7 out of 3,073 
Years Active: 2007-2020
Title: The Innovations of Juan Guillermo Paez in Cancer Treatment
Introduction
Juan Guillermo Paez, based in Boston, MA, is a prominent inventor in the field of cancer research and treatment. With a total of seven patents to his name, Paez has made significant contributions to the understanding and responsiveness of cancer therapies, particularly focusing on epidermal growth factor receptor (EGFR) targeting treatments. His work is crucial for enhancing precision medicine in oncology.
Latest Patents
Among his latest patents, Paez has developed a method to determine the responsiveness of cancer to epidermal growth factor receptor (EGFR) targeting treatments. This patent discloses methods and reagents that facilitate the detection of mutations associated with cancer responses to treatments. By identifying these mutations, healthcare providers can administer drugs like gefitinib and erlotinib to patients who are most likely to benefit from these tyrosine kinase inhibitors. This innovation is poised to improve treatment outcomes and patient quality of life.
Career Highlights
Paez has had a distinguished career, during which he has contributed to various research and clinical applications within leading institutions. He has been associated with The General Hospital Corporation and Dana-Farber Cancer Institute Inc., where he has worked on pivotal projects aimed at advancing cancer treatment methodologies.
Collaborations
Throughout his career, Juan Guillermo Paez has collaborated with esteemed colleagues like Daphne Winifred Bell and Daniel Arie Haber. These collaborations have helped foster an environment of innovation and have been instrumental in the development of groundbreaking treatments in the field of oncology.
Conclusion
Juan Guillermo Paez continues to be an influential figure in the realm of cancer research, with his patents serving as a testament to his dedication and innovative spirit. His work on EGFR-targeting treatments not only reflects his expertise but also embodies the forward momentum in cancer therapies that are tailored to the genetic make-up of patients. Through his innovations, Paez is making significant strides towards more effective and personalized cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile